Microbiome Changes in Travelers to Tropical Destinations

Status Recruiting

Clinical Trial Summary

The human gut contain a wide range of microorganisms creating the gut microbiome. The microbiome has great impact on metabolic and immunologic processes and responses. Travelers who travel to tropical destinations where the intestinal infection risk is high are prone to microbiome changes. During the current study the travelers will give feces specimen before and after the travel and their microbiome will be analyzed.

Clinical Trial Description

Individual differences in the microorganisms variety are affected by external factors such as food, age, geographic location, medication consumption, host genetics and exposure to microorganisms in early stages of life. During the current study the geographic location affect will be tested by comparing the microorganism environment before and after traveling to tropical destinations. ;

Study Design

Related Conditions & MeSH terms

Intestinal Diseases

Clinical Trial Details

NCT number	NCT02295254
Study type	Observational
Source	Sheba Medical Center
Contact	Eli Schwartz, MD, DTMH
Email	Eli.schwartz@sheba.health.gov.il
Status	Recruiting
Phase	N/A
Start date	September 2014
Completion date	January 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03032861` - The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?	N/A
Completed	`NCT02246647` - Biomarkers for Intestinal Permeability in Patients With Constipation
Recruiting	`NCT05322486` - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Active, not recruiting	`NCT01037049` - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks	Phase 2
Completed	`NCT01872286` - Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2	N/A
Completed	`NCT04080843` - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients	Phase 2
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Completed	`NCT02445365` - Remote Ischemic Conditioning in Patients With Ulcerative Colitis	N/A
Recruiting	`NCT04949282` - Spanish Series of Patients Treated With the Radionuclide Lutetium177
Active, not recruiting	`NCT01995942` - Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Completed	`NCT02647866` - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis	Phase 2
Completed	`NCT02693782` - Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS)	N/A
Recruiting	`NCT02831556` - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Not yet recruiting	`NCT02806206` - Prucalopride Prior to Small Bowel Capsule Endoscopy	Phase 4
Terminated	`NCT04102163` - Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment
Terminated	`NCT02550860` - Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function	Phase 3
Recruiting	`NCT02044952` - Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission	Phase 2/Phase 3
Completed	`NCT02227602` - Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease	N/A
Active, not recruiting	`NCT01028898` - Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome	N/A
Completed	`NCT00398203` - Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment	N/A